AmerisourceBergen Corporation is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
AmerisourceBergen Corp is an American drug wholesale company which provides distribution of brand name and generic pharmaceuticals and consulting related to medical business operations and patient services.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Healthcare is a central component of our measure of Humankind Value, as a large contribution to modern life expectancies has come from the last 150 years of medical innovation. AmerisourceBergen Corp. operates in a manner that is a net positive for humanity, primarily due to Economic Value ($16.2 B), Healthcare R&D ($15.0 B), and Pharmaceuticals ($7.1 B). Positive value from Healthcare R&D and Pharmaceuticals is linked to an estimate of 459,208.4 additional years lived by people worldwide. It produces economic value by offering to consumers goods and services that they value, paying employees for their labor in producing these goods and services, and providing value for shareholders. However, there is room for improvement with respect to Opioid Abuse (-$1.9 B) and Workplace Injuries (-$460.7 M). Economic Value and Workplace Injuries are attached to this company as a result of its direct business activities. Healthcare R&D, Pharmaceuticals, and Opioid Abuse are largely consequences of the actions of supply chain partners. While this company has a positive Humankind Value when studied in isolation, consideration of supply chain interactions pushes its Humankind Value higher.